$SRFM

Short Interest in Surf Air Mobility Inc. (NYSE:SRFM) Expands By 24.8%

Short interest in Surf Air Mobility Inc. (NYSE:SRFM) increased significantly by 24.8% in March, reaching over 10.5 million shares, which represents about 14.9% of the stock. Despite this, analysts have a mixed view, with a consensus "Hold" rating and an average price target of $3.13, following some recent downward revisions. The stock is currently trading at $1.06, below its 50- and 200-day moving averages.

Original reporting
MarketBeat · MarketBeat
Published Mar 31, 2026, 3:40 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Mar 31, 2026, 4:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Short Interest in Surf Air Mobility Inc. (NYSE:SRFM) Expands By 24.8% — source image
Decision brief

The 30-second read

$SRFMBearishMed
01

Why it matters

The surge in short interest and bearish sentiment scores suggest increased downside risk, but technical support levels and potential catalysts could mitigate declines.

02

Market read

The news is highly relevant for traders with exposure to SRFM, especially those engaging in short-term trading strategies.

03

What to watch

Potential upcoming positive catalysts such as new contracts or regulatory approvals could offset bearish signals.

Timing: Short-term to medium-term

Background

Surf Air Mobility Inc. has experienced recent volatility, with short interest increasing significantly, indicating growing bearish sentiment among traders.

Company-level read

Ticker impact

$SRFMBearishMedium confidence
Context

High relevance due to significant increase in short interest and bearish sentiment.

Expected impact

Moderate decline of approximately 10-15% over the next 1-3 months if current trends persist.

Evidence & confidence

The increase in short interest combined with bearish sentiment scores suggests increased downside risk. However, the stock's low current price and mixed analyst ratings imply potential support levels, preventing a more severe decline.

Market effects

Potential negative impact on the transportation and mobility sector due to increased bearish outlook.

Limited regional impact; primarily affecting investors in the US markets.

Minimal; company-specific news with limited global implications.

Counterpoint

The rise in short interest could be a contrarian indicator, suggesting that the stock may be oversold and due for a potential rebound if short sellers cover positions.

Key entities

  • Surf Air Mobility Inc.

    A regional airline and mobility service provider.

Related articles

$SRFMMed

Why is Surf Air Mobility stock sliding today?

Surf Air Mobility (SRFM) shares fell 2.4% in after-hours to $0.83 after the company released Q2 2026 results and filed an SEC Form 8-K. Analysts expected a Q2 loss of about $0.17 per share versus a $0.26 loss in Q1. The stock also faces an NYSE $1.00 compliance notice from July 24, with a six-month cure period.

$SRFMMed

SURF AIR MOBILITY INC. (SRFM): Results of Operations and Financial Condition

SURF AIR MOBILITY INC. (SRFM) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Surf Air Mobility Reports Second Quarter 2026 Financial Results, Meeting Revenue and Adjusted EBITDA Guidance Second Quarter Revenue of $29.5 Million, Driven By Over 100% Year-Over-Year Increase In Surf On Demand Private Charter Revenue, At the High End of the Guidan

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.